CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 36(Granted Patents)

Company Filing History:

14 out of 1,235

Nissan Chemical Industries Limited

Nissan Chemical Corporation

patents

where one patent can have more than one assignee

Years Active: 2008-2020

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10724028 - Ligand-binding fiber and cell culture substrate using said fiber (2020-07-28),

2. 10385052 - Tricyclic compound and JAK inhibitor (2019-08-20),

3. 9890165 - Tricyclic compound and JAK inhibitor (2018-02-13),

4. 9527828 - Method for expanding hematopoietic stem cells using heterocyclic compound (2016-12-27),

5. 9328085 - Heterocyclic compounds and expansion agents for hematopoietic stem cells (2016-05-03),

6. 9102602 - Method for producing isothiocyanate compound (2015-08-11),

7. 8946286 - Organic amine salts of aminobenzoic acid derivatives and method for producing same (2015-02-03),

8. 8889732 - Fused heterocyclic compounds and thrombopoietin receptor activators (2014-11-18),

9. 8658686 - Pyrazole compounds having therapeutic effect on multiple myeloma (2014-02-25),

10. 8318796 - Heterocyclic compounds and thrombopoietin receptor activators (2012-11-27),

11. 8134013 - Amide compound and thrombopoietin receptor activator (2012-03-13),

12. 8093251 - Nitrogen-containing heterocyclic compounds and thrombopoietin receptor activators (2012-01-10),

13. 7968542 - Thiophene compounds and thrombopoietin receptor activators (2011-06-28),

14. 7576115 - Heterocyclic compounds and thrombopoietin receptor activators (2009-08-18),

15. 7351841 - Heterocyclic compounds and thrombopoietin receptor activators (2008-04-01),

Title: Shunsuke Iwamoto: Pioneering Innovations in Medicine

Introduction:

Shunsuke Iwamoto, a brilliant inventor hailing from Funabashi, Japan, has made significant contributions to the world of medicine with his groundbreaking patents and inventions. With an impressive portfolio of 15 patents, Shunsuke Iwamoto stands out as a key figure in the field of biomedical innovation.

Latest Patents:

Among his latest patents is the creation of a Ligand-binding fiber and cell culture substrate using said fiber. This innovative invention involves immobilizing a ligand with affinity for a cell membrane receptor on a fiber precursor, allowing for ex vivo amplification of cells expressing the receptor. Additionally, Shunsuke Iwamoto developed a Tricyclic compound and JAK inhibitor, offering promising solutions for autoimmune, inflammatory, and allergic diseases.

Career Highlights:

Throughout his career, Shunsuke Iwamoto has been associated with prominent companies such as Nissan Chemical Industries Limited and Reprocell, Inc.. His expertise and dedication to innovation have fueled groundbreaking research and development initiatives, leading to the successful commercialization of novel pharmaceutical compounds.

Collaborations:

Collaborating with talented individuals such as Katsuaki Miyaji and Takanori Nakamura, Shunsuke Iwamoto has been able to leverage collective knowledge and expertise to push the boundaries of medical innovation. These fruitful collaborations have resulted in the development of cutting-edge technologies aimed at improving patient outcomes and advancing healthcare practices.

Conclusion:

In conclusion, Shunsuke Iwamoto's exceptional contributions to the field of medicine through his inventive patents and collaborations underscore his status as a visionary inventor. His unwavering commitment to pushing the boundaries of scientific discovery continues to inspire future generations of innovators to create a brighter and healthier world.

This text is generated by artificial intelligence and may not be accurate.